|
Code
|
2100E
|
|
MA number
|
EU/1/22/1685/018
|
|
Product Form:
|
sol inj 12(3x4)x0,5 ml/15 mg (pero napl. - multibal.)
|
|
MA Status:
|
E - Valid centralised marketing authorisation
|
|
Type of procedure:
|
EU
|
|
MAH, country:
|
Eli Lilly Nederland B.V., Netherland
|
|
Therapeutic Class:
|
18 - ANTIDIABETICA (VRÁTANE INZULÍNU)
|
|
ATC:
|
| A |
ALIMENTARY TRACT AND METABOLISM |
| A10 |
DRUGS USED IN DIABETES |
| A10B |
Blood glucose lowering drugs, excl. insulins |
| A10BX |
Other blood glucose lowering drugs, excl. insulins |
| A10BX16 |
Tirzepatide |
|
|
Shelf life:
|
24 |
|
Route of admin.:
|
Subcutaneous use
|
European Medicines Agency's database
